Pfizer low­ers cost of Prevnar vac­cine for char­ity use

Daily Local News (West Chester, PA) - - BUSINESS -

Drug­maker Pfizer says it’s re­duc­ing what it charges hu­man­i­tar­ian groups for its block­buster vac­cine against pneu­mo­nia, ear and blood in­fec­tions.

Pfizer Inc.’s move to re­duce Prevnar 13’s price to $3.10 per dose — but only for the groups’ use with refugees and in other emer­gency set­tings — fol­lows pres­sure since 2009 by groups such as Doc­tors With­out Bor­ders.

“This is definitely a step in the right di­rec­tion and will help to pro­tect mil­lions of vul­ner­a­ble chil­dren,” the char­ity said.

The big­gest U.S. drug­maker pre­vi­ously pre­ferred tax-de­ductible do­na­tions, which don’t im­pact Prevnar’s much-higher price. Pfizer’s top-sell­ing prod­uct, which re­quires three doses, brings it some $5 bil­lion a year.

Bri­tain’s Glaxo-Smith-Kline Plc in Septem­ber re­duced the price of its ri­val Syn­florix pneu­mo­coc­cal vac­cine to $3.05 per dose for use in hu­man­i­tar­ian emer­gen­cies.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.